BMY vs NVRI · P/E 17, rev $24.46B vs rev $511.4M
Bristol-Myers Squibb Company (BMY) versus Enviri Corporation (NVRI) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Enviri Corporation (NVRI) is a waste management company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported NVRI revenue for 2026-06-30 was $511.4M. Net income was -$406.7M. Revenue was down 7.0% from 2026-03-31 to 2026-06-30. NVRI currently screens at market cap $553.8M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. NVRI currently screens at market cap $553.8M.
Not investment advice. Open the BMY and NVRI stock pages for the full models.
Not investment advice.